ADENOCOR Solution for injection

Active ingredients: Adenine Deoxy Nucleoside

Product name and form

Adenocor 3 mg/ml Solution for injection.

Pharmaceutical Form

Solution for injection.

Clear, colourless solution.

Qualitative and quantitative composition

Each vial contains 6 mg of adenosine per 2 ml (3 mg/ml).

For the full list of excipients, see section 6.1.

Active Ingredient
Description

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node.

List of Excipients

Sodium chloride
Water for injections

Pack sizes and marketing

Clear, type I glass vials with chlorobutyl rubber closures secured with aluminium caps. Packs of 6 vials in plastic trays in cardboard cartons.

Marketing Authorization Holder
Authorization Dates

Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Date of first authorisation: 01 September 2010

Marketing authorization number:

PL 04425/0159

Drugs

Drug
Countries
Spain, Lithuania, Netherlands, Singapore, United Kingdom